We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


OpGen Strengthens Management Team to Accelerate Commercialization Strategy

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "OpGen Strengthens Management Team to Accelerate Commercialization Strategy"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

OpGen, Inc. has announced the appointment of Vadim Sapiro as chief information officer. In addition, the company announced the promotion and appointments of several key members of the executive committee. The organizational changes have been made to strengthen the management team and accelerate OpGen’s development and commercialization strategy. The company’s products enable rapid, accurate, high resolution whole genome analysis of microbes as well as more cost effective and accurate sequence assembly and finishing of human, animal, plant and microbial genomes.

“Vadim brings a wealth of knowledge and experience in information management and analysis to OpGen and will be focused on accelerating the commercialization of our portfolio of applications and tools for the sequence assembly, finishing and analysis markets,” said Doug White, chief executive officer of OpGen. “With the recent launch of our human, animal and plant sequencing applications in addition to our microbial whole genome mapping products, we will be expanding our capabilities to include web and cloud enabled analysis tools and databases. The recent management team appointments and promotions will positively position the company for commercial success and its next phase of growth.”

Mr. Sapiro joins OpGen’s management team as chief information officer and will be responsible for leading the development of OpGen’s bioinformatics applications, software, databases and information technology operations. Mr. Sapiro joins OpGen from SAIC-Frederick where he was senior vice president overseeing the Information Systems Program for the National Cancer Institute at Frederick with responsibility for information technology, scientific computing and bioinformatics. Among Mr. Sapiro’s projects were technical program management and operations for the cancer Biomedical Informatics Grid (caBIG™), the cancer Human Biobank (caHUB) and The Cancer Genome Atlas (TCGA). Prior to SAIC, Mr. Sapiro was vice president for information technology with the J. Craig Venter Institute. Mr. Sapiro is active in the regional and national technology and research communities, having served on many life sciences and biotech focused advisory boards and review committees. Mr. Sapiro holds a B.S. in mathematics and computer science from the University of Maryland.

In addition to the hiring of Mr. Sapiro, the company announced the promotion of Richard Moore, Ph.D., MD, to chief scientific officer. In his new role, Dr. Moore will be responsible for leading the R&D organization and scientific collaborations with the genetics research, public health and clinical research communities. He joined OpGen as vice president of diagnostic systems in October 2008. Dr. Moore obtained an M.D. and a Ph.D. in cellular immunology from the University of Maryland at Baltimore and a B.S. in chemical and nuclear engineering from the University of Maryland, College Park.

Nick Stiso, Ph.D., was named vice president of manufacturing operations and is responsible for all manufacturing operations of OpGen’s Argus Whole Genome Mapping System, consumables and reagents kits. He brings more than 25 years of experience to OpGen with a strong track record in the development and management of successful manufacturing and support operations for life science systems and IVD products. Prior to joining OpGen, Dr. Stiso held executive level positions in development and manufacturing operations at Biosite Diagnostics, Accumetrics, Syva Co, GeneOhm Sciences and Miles Laboratories. Dr. Stiso earned a B.S. in chemistry from Georgetown University and a Ph.D. in physical chemistry from Michigan State University.

Judy Macemon was named vice president of marketing and is responsible for OpGen’s product portfolio management commercial strategies and tactics. Ms. Macemon brings 30 years of experience with a successful track record of leading commercial strategy development, building high performance marketing teams and global product launches in both the life science and clinical diagnostics markets. Before joining OpGen, Ms. Macemon was vice president of marketing at Helixis, Inc (now Illumina). Prior to Helixis, she held senior marketing roles at Life Technologies, Stratagene (now Agilent), MicroProbe and Becton Dickinson. Ms. Macemon has a B.S. in medical technology from Louisiana State University, M.S. in clinical microbiology from Texas Women’s University and M.B.A. from San Diego State University.